Results 1 to 10 of about 13,223 (143)

Case Report: Development of persistent genital arousal disorder due to a possible combination of medications [PDF]

open access: yesFrontiers in Psychiatry
ObjectivePersistent Genital Arousal Disorder (PGAD) is a rare and distressing condition characterized by persistent genital arousal in the absence of sexual desire.
Ludek Fiala   +3 more
doaj   +2 more sources

A Matched Case-Control Study Examining the Association Between Exposure to Depot Medroxyprogesterone Acetate and Cerebral Meningioma Using an Active Comparator [PDF]

open access: yesCurrent Oncology
The recent literature has reported an increased association between the use of depot medroxyprogesterone acetate (dMPA) and cerebral meningioma (CM). Prior studies have been limited in generalizability and did not use an active comparator as a control ...
Russell Griffin, Rebecca Arend
doaj   +2 more sources

Medroxyprogesterone promotes neuronal survival after cerebral ischemic stroke by inhibiting PARthanatos [PDF]

open access: yesFrontiers in Pharmacology
IntroductionCerebral ischemic stroke (CIS) is caused by the interruption of cerebral blood circulation due to thrombosis or embolism and is the second-leading cause of mortality worldwide.
Chang-Ling Yue   +12 more
doaj   +2 more sources

The Association Between Medroxyprogesterone Acetate Exposure and Cerebral Meningioma Among a Medicaid Population [PDF]

open access: yesEpidemiologia
Background/Objectives: Medroxyprogesterone acetate (MPA) is a synthetic contraceptive that can be used orally or as a once-every-three-month injection (i.e., depot MPA [dMPA]).
Lindy M. Reynolds   +2 more
doaj   +2 more sources

The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma [PDF]

open access: yesBMC Medical Imaging
Background It will be important to noninvasively evaluate the efficacy of treatment for patients with atypical endometrial hyperplasia (AEH) and endometrial carcinoma (EC) who wish to have children. The study aimed to explore the feasibility of diffusion-
Mingming Liu   +5 more
doaj   +2 more sources

Effects of Donepezil and Medroxyprogesterone Versus Placebo on Weaning in Adult Patients With Non-Pulmonary Etiologies Receiving Invasive Mechanical Ventilation: A triple‐blind Randomized Clinical Trial

open access: yesFrontiers in Pharmacology, 2021
Background: Medroxyprogesterone and donepezil could be used as respiratory stimulants in ventilated patients. However, no randomized placebo-controlled trial is available to confirm this approach and compare these drugs.
Zahra Alizadeh   +4 more
doaj   +1 more source

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response

open access: yesFrontiers in Endocrinology, 2021
ObjectiveTo compare the clinical outcomes of dydrogesterone (DYG) and medroxyprogesterone (MPA) in the progestin-primed ovarian stimulation (PPOS) protocol for patients with poor ovarian response (POR).Patients and MethodsThis was a retrospective cohort ...
Junwei Zhang   +6 more
doaj   +1 more source

Medroxyprogesterone acetate improves propionic acid-induced autism rat model and magnetic resonance spectroscopic correlation

open access: yesBangladesh Journal of Pharmacology, 2022
The protective effect of medroxyprogesterone acetate on propionic acid-induced autism in rats was evaluated. For this purpose, 30 rats were divided into three groups.
Mehmet Fatih Bozkurt   +4 more
doaj   +1 more source

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery

open access: yesPharmaceutics, 2020
Following oral administration, the bioavailability of progestogens is very low and highly variable, in part due to metabolism by cytochrome P450 enzymes found in the mucosa of the small intestine.
Zoe Coombes   +6 more
doaj   +1 more source

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial

open access: yesMedicina, 2022
Background and objectives: Abnormal uterine bleeding is a significant clinical and gynaecological concern that necessitates its safe and effective treatment.
Suhail Ahmad Mir   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy